Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2025)

ENDRA Life Sciences has reported Cash from Investing Activities over the past 5 years, most recently at -$45000.0 for Q1 2021.

  • Quarterly Cash from Investing Activities fell 101.34% to -$45000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was -$45000.0 through Dec 2021, up 40.27% year-over-year, with the annual reading at -$3.0 million for FY2025, 23479.87% down from the prior year.
  • Cash from Investing Activities was -$45000.0 for Q1 2021 at ENDRA Life Sciences, up from -$64850.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $11867.0 in Q3 2020 and troughed at -$100000.0 in Q3 2018.
  • The 5-year median for Cash from Investing Activities is -$22350.0 (2020), against an average of -$30198.9.
  • The largest YoY upside for Cash from Investing Activities was 69.07% in 2020 against a maximum downside of 326.61% in 2020.
  • A 5-year view of Cash from Investing Activities shows it stood at -$7862.0 in 2017, then plummeted by 1171.94% to -$100000.0 in 2018, then soared by 61.64% to -$38357.0 in 2019, then tumbled by 69.07% to -$64850.0 in 2020, then surged by 30.61% to -$45000.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Cash from Investing Activities are -$45000.0 (Q1 2021), -$64850.0 (Q4 2020), and $11867.0 (Q3 2020).